Bard Associates Inc. decreased its holdings in Stericycle, Inc. (NASDAQ:SRCL) by 0.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,210 shares of the business services provider’s stock after selling 100 shares during the quarter. Stericycle accounts for approximately 1.1% of Bard Associates Inc.’s holdings, making the stock its 23rd biggest position. Bard Associates Inc.’s holdings in Stericycle were worth $2,535,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of SRCL. BlackRock Inc. raised its position in Stericycle by 3,492.3% in the 1st quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock worth $421,877,000 after buying an additional 4,947,900 shares during the last quarter. Ameriprise Financial Inc. raised its position in Stericycle by 144.9% in the 1st quarter. Ameriprise Financial Inc. now owns 1,901,243 shares of the business services provider’s stock worth $157,594,000 after buying an additional 1,124,908 shares during the last quarter. Schroder Investment Management Group purchased a new position in Stericycle in the 2nd quarter worth about $80,497,000. Thompson Siegel & Walmsley LLC purchased a new position in Stericycle in the 2nd quarter worth about $33,710,000. Finally, Morgan Stanley raised its position in Stericycle by 110.4% in the 1st quarter. Morgan Stanley now owns 625,893 shares of the business services provider’s stock worth $51,881,000 after buying an additional 328,431 shares during the last quarter. 93.72% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have weighed in on SRCL. Jefferies Group LLC set a $108.00 target price on Stericycle and gave the stock a “buy” rating in a research report on Friday, August 11th. BidaskClub lowered Stericycle from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Barclays PLC reissued an “overweight” rating and issued a $100.00 target price on shares of Stericycle in a research report on Wednesday, August 9th. Robert W. Baird lowered shares of Stericycle from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $74.00 to $73.00 in a research report on Monday, May 15th. Finally, Zacks Investment Research lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research report on Monday, August 7th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $81.25.

Stericycle, Inc. (SRCL) traded up 1.83% on Friday, reaching $70.26. The company’s stock had a trading volume of 737,301 shares. The company’s market capitalization is $6.00 billion. The firm has a 50-day moving average of $73.73 and a 200 day moving average of $79.54. Stericycle, Inc. has a 12-month low of $68.62 and a 12-month high of $88.00.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The company had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. During the same period last year, the company earned $1.18 earnings per share. Stericycle’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts anticipate that Stericycle, Inc. will post $4.60 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/10/stericycle-inc-srcl-holdings-trimmed-by-bard-associates-inc.html.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.